Sonova Group in the news

Sonova's stock rose by 0.4% to 253.60 CHF, nearing its 52-week high, with positive forecasts for dividends and earnings per share in 2027.

Sonova Holding AG's total equity was MXN59,182 million as of March 2026, with GuruFocus rating it as significantly undervalued.

Sonova shares increased by 0.2% to 253.20 CHF, with an upcoming Q2 2027 earnings report and analyst predictions for 2027 EPS at 11.00 CHF.

Sonova's stock increased by 1.6% to 255.60 CHF on Tuesday morning, with upcoming earnings reports and dividend expectations.

Sonova Holding AG's working capital changes are detailed, with data from FactSet Research Systems Inc. and copyright by the American Bankers Association.

This document outlines research tools, product offerings, and educational resources related to Sonova Holding AG's stock earnings transcripts.

This document from GuruFocus.com provides a stock forecast for Sonova Holding AG, along with disclaimers about its role as an information provider and not an investment advisor.

Sonova shares saw a 2.0 percent increase to 256.60 CHF, nearing a 52-week high, with upcoming Q2 2027 financial results and increased dividend expectations.

Sonova's stock increased by 2.0 percent to CHF 256.60, reaching a new 52-week high, with analysts expecting higher dividends and earnings per share in 2027.

Sonova's stock price saw a slight increase on SIX SX, with forecasts for dividends and earnings per share showing growth, and upcoming Q2 2027 financial results expected on November 12, 2026.

Sonova's stock is near its 52-week high, supported by solid revenue growth and strong EBITDA, with upcoming half-year results set to provide the next financial update.

Sonova's stock price rose 1.21% to EUR 270.90 in after-hours trading on October 5, 2026, following its recognition as Switzerland's top innovative large company for its AI-powered hearing technology and Phonak's EON hearing aids.

Sonova, a hearing solutions company, ranked first in innovation, is launching new products, reported strong fiscal year 2025/26 financial results, and forecasts continued growth.

Sonova's stock decreased pre-market on October 5, 2026, while the company was recognized as a top innovator and launched a new AI-powered hearing aid portfolio.

Sonova achieved the top position in Switzerland's innovation ranking for large companies, with its stock maintaining a price of EUR 267.65 in recent trading.

Sonova's stock trades near its yearly high after being ranked top for innovation and reporting strong sales growth for FY 2025/26, though analysts maintain a cautious outlook.

Sonova stock costs EUR 267.65; the company was ranked first among Switzerland's most innovative large companies.

Sonova Holding AG develops, produces, and distributes hearing instruments and cochlear implants under multiple brands.

Sonova's stock decreased by 0.6% to 248.80 CHF on Friday afternoon, with Q2 2027 results and an EPS of 10.97 CHF for 2027 anticipated.

Sonova's stock experienced a slight decline on Friday, trading at 247.40 CHF, while future financial results and dividends are anticipated.